One-Year Safety Analysis of the COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133(+) Bone Marrow Stem Cells to Placebo in Patients after Acute Myocardial Infarction and Left Ventricular Dysfunction

Bone marrow stem cell therapy has emerged as a promising approach to improve healing of the infarcted myocardium. Despite initial excitement, recent clinical trials using non-homogenous stem cells preparations showed variable and mixed results. Selected CD133(+) hematopoietic stem cells are candidat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansour, Samer, Roy, Denis-Claude, Bouchard, Vincent, Stevens, Louis Mathieu, Gobeil, Francois, Rivard, Alain, Leclerc, Guy, Reeves, François, Noiseux, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200002/
https://www.ncbi.nlm.nih.gov/pubmed/22046562
http://dx.doi.org/10.1155/2011/385124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3200002/
https://www.ncbi.nlm.nih.gov/pubmed/22046562
http://dx.doi.org/10.1155/2011/385124

Ejemplares similares